A detailed history of 5 Am Venture Management, LLC transactions in Rallybio Corp stock. As of the latest transaction made, 5 Am Venture Management, LLC holds 3,630,724 shares of RLYB stock, worth $3.59 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares
3,630,724
Previous 3,630,724 -0.0%
Holding current value
$3.59 Million
Previous $4.87 Million 12.7%
% of portfolio
1.69%
Previous 2.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$4.37 - $8.75 $437,000 - $875,000
-100,000 Reduced 2.68%
3,630,724 $20.7 Million
Q2 2022

Aug 15, 2022

SELL
$6.26 - $13.65 $1.57 Million - $3.41 Million
-250,000 Reduced 6.28%
3,730,724 $28.2 Million
Q1 2022

May 16, 2022

SELL
$6.91 - $15.04 $1.45 Million - $3.16 Million
-210,000 Reduced 5.01%
3,980,724 $27.8 Million
Q3 2021

Nov 15, 2021

BUY
$10.83 - $23.4 $45.4 Million - $98.1 Million
4,190,724 New
4,190,724 $73.7 Million

Others Institutions Holding RLYB

About Rallybio Corp


  • Ticker RLYB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,000
  • Market Cap $31.8M
  • Description
  • Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...
More about RLYB
Track This Portfolio

Track 5 Am Venture Management, LLC Portfolio

Follow 5 Am Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 5 Am Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 5 Am Venture Management, LLC with notifications on news.